Celebrating 25 years Est 1999-2024
*Across 3 years $2276.64 only $796.82
Pfizer Inc on Friday said it hopes to have at least eight landmark cancer drugs by 2030, as it laid the vision for it ...
Pfizer Inc on Tuesday backed its 2024 financial guidance and said it was "encouraged" by its fourth-quarter performan ...
Pfizer Inc and Astellas Pharma Inc on Friday celebrated the European Medicines Agency's decision to validate its appl ...
Pfizer Inc on Tuesday said that the US Food & Drug Administration has agreed to review its licence application to get ...
York City-based pharmaceutical firm - European Commission approves TALZENNA (talazoparib), an oral poly ADP-ribose pol ...
Pharmaceutical firms Pfizer Inc and BioNTech SE are suing the governments of Poland and Hungary alleging they failed ...
Astellas Pharma Inc, Merck & Co Inc and Pfizer Inc on Friday announced expanded approval in the US for Keytruda combi ...
Pfizer Inc on Wednesday set out weaker than expected financial guidance for 2024, sending its stock lower. Pfizer s ...
Pfizer Inc on Tuesday said that it expects to close its acquisition of Seagen Inc by Thursday, after receiving all re ...
Pfizer Inc on Friday said its targeted immunotherapy Elrexfio has won conditional marketing authorisation from the Eu ...
US drugmaker Pfizer Inc on Friday said it would end a clinical trial of its developmental weight loss pill after high ...
Pfizer Inc is to cut around 500 jobs at its site in Sandwich, Kent in the UK. The company said the move is part of p ...
Pfizer Inc on Tuesday said it swung to a loss in the third quarter, tracking plunging revenue and reaffirming its dec ...
Pfizer Inc on Friday said the US Food & Drug Administration has approved Penbraya. The New York-based pharmaceutical ...
The EU said Thursday it had given the green light for US pharmaceutical firm Pfizer Inc's USD43-billion acquisition o ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.